PATIENT-REPORTED OUTCOME DATA FROM THE LUX-LUNG 8 PHASE III GLOBAL TRIAL OF AFATINIB VERSUS ERLOTINIB AS SECOND-LINE TREATMENT FOR ADVANCED SQUAMOUS CELL CARCINOMA OF THE LUNG FOLLOWING FIRST-LINE PLATINUM-BASED CHEMOTHERAPY.

Lee K., GÖKER E., COŞKUN H. Ş., Gordon J., Gadgeel S.

ONCOLOGY NURSING FORUM, vol.43, no.2, 2016 (SCI-Expanded) identifier

  • Publication Type: Article / Abstract
  • Volume: 43 Issue: 2
  • Publication Date: 2016
  • Journal Name: ONCOLOGY NURSING FORUM
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Akdeniz University Affiliated: Yes